39 /100
MEDIUM RISK
Score updated May 30, 2026

ARWR — Arrowhead Pharmaceuticals, Inc. Dilution Risk Tracker

Track ARWR dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ARWR — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
0
📊 Float Risk
7
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
7%
🔁 Convertible Conversion 15%
• Convertible debt present: 6.4% potential dilution
🔔 Track ARWR — Get forecast alerts →

💹 Market Data

Market Cap$10.97B
Shares Outstanding140.86M
Float122.78M
Cash$1.78B
Debt$1.38B
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 3.3% shares (2025Q4 vs prior)
408 institutional holders · 121.20M shares
#1 BlackRock, Inc. 21.32M shares
#2 VANGUARD GROUP INC 15.29M shares
#3 Avoro Capital Advisors LLC 10.62M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest12.93M
Days to Cover7.0
% of Float10.5%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Mar 31, 2026
xbrl XBRL WARRANT Sep 30, 2025
4 INSIDER TRANSACTION Mar 09, 2026
Full SEC filing analysis available with free account →

📰 Recent News

No recent news
Track ARWR Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ARWR — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: ADAG AIEV AIP ALLO ALOY
🔬 More Research for ARWR
📊 ARWR FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 ARWR Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.